Megan Elizabeth Bowles Clowse, MD

Associate Professor of Medicine
Campus mail Baker House 07, Duke South, Trent Drive, Durham, NC 27710
Phone (919) 681-2045
Email address megan.clowse@duke.edu

Dr. Megan Clowse is an Associate Professor of Medicine, Rheumatology and Immunology.  Her clinical research focuses on the management of rheumatologic diseases in pregnancy. Her current studies include identification of causes for the high rate of infertility among women with rheumatoid arthritis and understanding how psoriatic arthritis impacts pregnancy.

She has conducted studies on vasculitis and ovarian function and pregnancy. She is the Director of the Vasculitis-Pregnancy Registry, an online pregnancy registry for women with these rare conditions.  Additionally, she has collected prospective pregnancies in women with rheumatic disease in the Duke Autoimmunity in Pregnancy Registry that includes clinical data, pregnancy outcomes, and a large sample repository.

In Their Words

Education and Training

  • Fellow in Rheumatology, Medicine, Johns Hopkins University, 2002 - 2005
  • Medical Residetn, Medicine, Johns Hopkins University, 1999 - 2002
  • M.D., Vanderbilt University, 1999
  • M.P.H., University of California at Los Angeles, 1994

Publications

Afzali, A, Clowse, MEB, Scheuerle, AE, Chambers, C, Kimball, AB, Cush, JJ, Cooney, M, Shaughnessy, L, Vanderkelen, M, and Foerger, F. "CHARACTERISTICS AND OUTCOMES OF PROSPECTIVELY REPORTED PREGNANCIES EXPOSED TO CERTOLIZUMAB PEGOL FROM A SAFETY DATABASE." February 2018.

Scholars@Duke

Birru Talabi, M, Clowse, MEB, Schwarz, EB, Callegari, LS, Moreland, L, and Borrero, S. "Family Planning Counseling for Women With Rheumatic Diseases." Arthritis care & research 70, no. 2 (February 2018): 169-174. (Review)

PMID
28437837
Full Text

Afzali, A, Clowse, MEB, Scheuerle, AE, Chambers, C, Kimball, AB, Cush, JJ, Cooney, M, Shaughnessy, L, Vanderkelen, M, and Förger, F. "28 CHARACTERISTICS AND OUTCOMES OF PROSPECTIVELY REPORTED PREGNANCIES EXPOSED TO CERTOLIZUMAB PEGOL FROM A SAFETY DATABASE." January 2018.

Full Text

Afzali, A, Clowse, MEB, Scheuerle, AE, Chambers, C, Kimball, AB, Cush, JJ, Cooney, M, Shaughnessy, L, Vanderkelen, M, and Forger, F. "CHARACTERISTICS AND OUTCOMES OF PROSPECTIVELY REPORTED PREGNANCIES EXPOSED TO CERTOLIZUMAB PEGOL FROM A SAFETY DATABASE." January 2018.

Scholars@Duke

Sadun, RE, Wells, MA, Balevic, SJ, Lackey, V, Aldridge, EJ, Holdgagte, N, Mohammad, S, Criscione-Schreiber, LG, Clowse, MEB, and Yanamadala, M. "Increasing contraception use among women receiving teratogenic medications in a rheumatology clinic." Bmj Open Quality 7, no. 3 (January 2018): e000269-null.

PMID
30094345
Full Text

Clowse, ME, Förger, F, Hwang, C, Thorp, J, Dolhain, RJ, van Tubergen, A, Shaughnessy, L, Simpson, J, Teil, M, Toublanc, N, Wang, M, and Hale, TW. "Minimal to no transfer of certolizumab pegol into breast milk: results from CRADLE, a prospective, postmarketing, multicentre, pharmacokinetic study." Annals of the Rheumatic Diseases 76, no. 11 (November 2017): 1890-1896.

PMID
28814432
Full Text

Eudy, AM, Petri, M, Fischer-Betz, R, Mokbel, A, Nalli, C, Andreoli, L, Tincani, A, Molad, Y, Balevic, S, and Clowse, MEB. "Hydroxychloroquine in Lupus Pregnancy: A Meta-Analysis of Individual Participant Data.": WILEY, October 1, 2017.

Scholars@Duke

Eudy, AM, Petri, M, Fischer-Betz, R, Mokbel, A, Nalli, C, Andreoli, L, Tincani, A, Molad, Y, Balevic, S, and Clowse, MEB. "Hydroxychloroquine in Lupus Pregnancy: A Meta-Analysis of Individual Participant Data.": WILEY, October 1, 2017.

Scholars@Duke

Haroun, T, Eudy, AM, Jayasundara, M, Nowell, WB, Curtis, JR, White, CW, Crow-Hercher, R, Ginsberg, SD, and Clowse, MEB. "Tough Choices: Understanding the Medication Decision-Making Process for Women with Inflammatory Arthritis during Pregnancy and Lactation.": WILEY, October 1, 2017.

Scholars@Duke

Haroun, T, Eudy, AM, Jayasundara, M, Nowell, WB, Curtis, JR, White, CW, Crow-Hercher, R, Ginsberg, SD, and Clowse, MEB. "Tough Choices: Understanding the Medication Decision-Making Process for Women with Inflammatory Arthritis during Pregnancy and Lactation.": WILEY, October 1, 2017.

Scholars@Duke

Pages